Tech Company Financing Transactions
Opsonix Funding Round
Opsonix, based in Wakefield, scored $1 million in investment from private investors.
Transaction Overview
Company Name
Announced On
11/10/2017
Transaction Type
Debt
Amount
$1,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 2 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
301 Edgewater Pl. 100
Wakefield, MA 01880
USA
Wakefield, MA 01880
USA
Phone
Undisclosed
Website
Email Address
Overview
Opsonix is developing and commercializing a pathogen-extracting therapy that uses its proprietary pathogen-capture proteins to remove infectious microbes and the toxins they release from circulating blood, offering a new broad-spectrum approach to transform the treatment of blood-borne infectious diseases, including sepsis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Devroe
Chief Financial Officer
Daniel Geffken
Chief Scientific Officer
Donald Ingber
VP - R & D
Greg Martin
Browse more venture capital transactions:
Prev: 11/10/2017: EclecticIQ venture capital transaction
Next: 11/10/2017: CheckedUp venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record all VC transactions involving tech companies. All VC database entries on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs